Clinical Features and Therapeutic Efficacy of Childhood Rhabdomyosarcoma
Tang Xue,Guo Xia,Yang Xue,Wan Zhi,Ai Yuan,Jiang Mingyan,Gao Ju
DOI: https://doi.org/10.3877/cma.j.issn.1673-5250.2016.02.001
2016-01-01
Abstract:Objective To explore the clinical and pathological characteristics,therapeutic efficacy and outcomes of childhood rhabdomyosarcoma (RMS),aiming to formulate a standardized management approach and to improve long-term prognosis.Methods Clinical data of 26 children with RMS admitted to the Department of Pediatrics,West China Second University Hospital,Sichuan University,from August 2010 to September 201 5 was collected and analyzed retrospectively.Among 23 cases of RMS with combination chemotherapy and regular follow-up,there were 12 cases in continuous complete remission (CR),2 cases achieving partial remission (PR),and 9 cases with RMS progression/recurrence.Excluding 2 cases of PR,they were divided into continuous CR group (n=12)and RMS progression/relapse group (n =9).There were no significant differences between two groups in terms of gender proportion and median age at onset (P > 0.05 ),respectively.The pathology diagnosis and typing,immunohistochemistry,cytogenetics,stage of RMS and risk and prognosis were analyzed.Kaplan-Meier method was used to calculate and compare rates of 2-year overall survival (OS)and event free survival (EFS)between different factors,while multivariate non-conditional logistic analysis was employed to identify RMS progression/relapse risk factors.The study protocol was approved by the Ethical Review Board of Investigation in Human Being of West China Second University Hospital,Sichuan University.Results ① There were 1 7 boys and 9 girls among 26 cases of RMS children,whose median age at onset of RMS was 60.5 months (10-1 71 months). There was no significant difference in terms of age at tumor onset between boys and girls (T=0.1 70, P =0.874).②There were 1 9 cases with embryonal RMS (73.1%)and 7 cases with alveolar RMS (26.9%).The FOXO1A fusion gene was detected in only one case with alveolar RMS.Positive expressions of myogenin and desmin were documented in 24 cases (100.0%)and 23 cases (95.8%) out of 24 patients in whom immunohistochemical staining was undertaken.Among 9 cases of RMS (including 5 cases of embryonal RMS and 4 cases of alveolar RMS)who were admitted after October 2013,FOXO1A gene translocation was detected by fluorescence in situ hybridization (FISH)in only one case of alveolar RMS.③ RMS stage Ⅰ,Ⅱ,Ⅲ and Ⅳ were assigned to 8,1,9 and 8 cases, respectively before treatment, as determined by Intergroup Rhabdomyosarcoma Study (ISR ) pretreatment staging system.There were 8,10 and 8 cases stratified to RMS low,intermediate and high-risk groups.④ Twenty-three cases received combination chemotherapy,with 7 cases receiving additional local radiotherapy and 2 cases with peripheral blood stem cell transplantation.Overall rate of CR was 73.9% (1 7/23).Up to the follow-up endpoint,continuous CR and PR were documented in 12 and 2 cases,while tumor progression and tumor relapse were identified in 4 and 5 patients, respectively.Five patients died,including 4 cases with tumor regression and 1 relapsed case.⑤With a median follow-up of 13 months (2-50 months),the rates of 2-year OS and EFS were 78% and 52%, respectively.The rates of 2-year OS and EFS were significantly higher in children with age at onset <10 years old than those in children with age at onset ≥ 10 years old (χ2 = 8.889,P = 0.003;χ2 =4.201,P =0.04).And the rates of 2-year OS and EFS were significantly higher in patients (13 cases) who achieved CR with 4 or fewer chemotherapy courses than those (8 cases)who failed to achieve CR (χ2 = 7.01 7,P = 0.008 ). Similarly, there were more cases who failed to achieve CR with chemotherapy courses >4 in the RMS progression/relapse group than those cases in continuous CR group (P =0.007).⑥Nevertheless,both age at onset ≥10 years old and CR-targeting chemotherapy courses ≤ 4 were not independent risk factors for the prognosis of RMS in the RMS progression/relapse group,as revealed by multivariable logistic regression (OR =0.255,95% CI :0.012-5.1 73, P =0.432;OR=0.039,95% CI :0.002-0.975,P =0.058).Conclusions Embryonal RMS is more prevalent in children.Although overall rates of CR could be over 70%,RMS progression and relapse occur in substantial cases. Generally, prognosis remains poor in older patients and those with inadequate early therapeutic responses.Multidisciplinary cooperative approaches should be adopted in order to improve therapeutic efficacy and long-term outcomes.